Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
FDA approves drug from Boston-based company to treat pain without opioid effects
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Nature20h
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...
University of the Pacific researchers develop extended-release opioid reversal drug
A team of researchers at the University of the Pacific has developed an injectable version of Narcan that releases the opioid ...
Stockton researchers share how a new life-saving drug could offer help in opioid crisis
A University of Pacific professor and his team developed a drug delivery system that they say could offer a game-changing ...
Denver Health unveils naloxone vending machine that offers live-saving drug free of charge
Denver Health unveiled a no-cost naloxone vending machine on its hospital campus on Monday. The vending machine distributes ...
BioPharma Dive21h
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...
What to Know: FDA Approves Non-Opioid Pain Medication, Journavx
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...